Y. Satoh

发表

Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel disease.

M. Sata, K. Mitsuyama, A. Suzuki, 2006, International journal of molecular medicine.

Activation of c‐Jun N‐terminal kinase (JNK) signalling in experimentally induced gastric lesions in rats

M. Sata, K. Mitsuyama, A. Suzuki, 2006, Clinical and experimental immunology.

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

David W. Anderson, A. Manning, Y. Satoh, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Organic synthesis using haloboration reactions 11. A formal carboboration reaction of 1-alkynes and its application to the di- and trisubstituted alkene synthesis

Y. Satoh, N. Miyaura, S. Hara, 1988 .

Stereospecific Synthesis of the Fungal Prohormone (±)-Trisporol B via the Palladium-Catalyzed Cross-Coupling Reaction of 1-Alkenylborane with 1-Haloalkene

Y. Satoh, N. Miyaura, S. Hara, 1986 .

Membrane space structure with sterical support of booms and cables

H. Yamakawa, M. Natori, T. Miyashita, 2016 .

Synthesis of a Monolithic Carbon-Based Acid Catalyst with a Honeycomb Structure for Flow Reaction Systems

Y. Satoh, S. Mukai, I. Ogino, 2013 .

Synthesis of optically active .beta.-lactams by the photolytic reaction of imines with optically active chromium carbene complexes

Y. Satoh, L. Hegedus, D. Dvořák, 1990 .

Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury.

Y. Satoh, B. Bennett, D. Giegel, 2012, Bioorganic & medicinal chemistry letters.

Structural study of a cell-wall mannan of Saccharomyces kluyveri IFO 1685 strain. Presence of a branched side chain and beta-1,2-linkage.

Y. Satoh, S. Suzuki, N. Shibata, 1993, European journal of biochemistry.

JNK mediates hepatic ischemia reperfusion injury.

D. Brenner, G. K. Bilter, J. Westwick, 2005, Journal of hepatology.

A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.

Chin-Chun Lu, Y. Satoh, L. LeBrun, 2017, Journal of medicinal chemistry.

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.

A. Fujimori, Y. Satoh, M. Takanashi, 1997, European journal of pharmacology.

Suppression of Alloreactivity and Allograft Rejection by SP600125, a Small Molecule Inhibitor of c-Jun N-terminal Kinase

Y. Satoh, B. Bennett, N. Sato, 2007, Transplantation.

Benzoxepin and benzothiepin derivatives as potent, orally active inhibitors of 5-lipoxygenase

T. Kowalski, Y. Satoh, A. Libby, 1994 .

Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy model

T. Kowalski, Y. Satoh, J. Peppard, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

Synthesis of Sulfonic Acid Functionalized Silica Honeycombs

Y. Satoh, S. Mukai, I. Ogino, 2013 .

Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs.

A. Fujimori, Y. Satoh, M. Shibasaki, 1997, European journal of pharmacology.

Synthesis and antifungal activities of novel 1,3-beta-D-glucan synthase inhibitors. Part 1.

T. Watanabe, Y. Satoh, I. Horii, 2001, Bioorganic & medicinal chemistry letters.

Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors.

K. Chan, Y. Satoh, A. Jeng, 2001, Bioorganic & medicinal chemistry letters.

Synthesis of 4-substituted phenylalanine derivatives by cross-coupling reaction of p-boronophenylalanines

Y. Satoh, C. Gude, F. Firooznia, 1997 .

ANovel Compound , NK 150460 , Exhibits Selective Antitumor Activity against Breast Cancer Cell Lines through Activation of Aryl Hydrocarbon Receptor

K. Nishikawa, S. Horie, Y. Satoh, 2015 .

A Novel Compound, NK150460, Exhibits Selective Antitumor Activity against Breast Cancer Cell Lines through Activation of Aryl Hydrocarbon Receptor

K. Nishikawa, S. Horie, Y. Satoh, 2014, Molecular Cancer Therapeutics.

Optically active quaternary carbon centers from the photoaddition of chromium-alkoxycarbene complexes and optically active thiazolines

Y. Satoh, L. Hegedus, N. Suzuki, 1992 .

Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action.

D. Hoyer, Y. Satoh, D. Hoyer, 2000, Journal of medicinal chemistry.

Synthesis of amino-.beta.-lactams by the photolytic reaction of imines with pentacarbonyl[(dibenzylamino)carbene]chromium(0)

Y. Satoh, L. Hegedus, C. Borel, 1987 .

Application of 5-lithiotetrazoles in organic synthesis

Y. Satoh, N. Marcopulos, 1995 .

Synthesis of tetrazole analogs of α-amino acids by alkylation of a Schiff base of α-aminomethyltetrazole

Y. Satoh, E. Wallace, N. Marcopulos, 1998 .

Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.

T. Kowalski, Y. Satoh, J. Stanton, 1993, Journal of medicinal chemistry.

Organic synthesis using haloboration reaction xv. A new synthesis of α,β-unsaturated esters by the highly chemoselective reaction of B-I-9-BBN-ethoxyethyne adduct with aldehydes

Y. Satoh, S. Hara, A. Suzuki, 1989 .

ORGANIC SYNTHESIS USING HALOBORATION REACTION; PART VI. SYNTHESIS OF 2-BROMOALKANALS FROM 1-ALKYNES

Y. Satoh, S. Hara, H. Koshino, 1985 .

Organic synthesis using haloboration reaction, II. A stereo- and regioselective synthesis of [Z]-1-Alkynyl-2-halo-1-alkenes

Y. Satoh, S. Hara, A. Suzuki, 1983 .

Enantioselective Synthesis of 4-Substituted Phenylalanines by Cross-Coupling Reactions.

Y. Satoh, C. Gude, F. Firooznia, 1999 .

An Efficient Synthesis of 4-Aryl-2,6-di-tert-butylphenols by a Palladium-Catalyzed Cross-Coupling Reaction

Y. Satoh, Cheng Shi, 1994 .

An Efficient Synthesis of 4‐Aryl‐2,6‐di‐tert‐butylphenols by a Palladium‐Catalyzed Cross‐Coupling Reaction.

Y. Satoh, Cheng Shi, 1995 .

Synthesis of Amino-β-lactams by the Photolytic Reaction of Imines with Pentacarbonyl((dibenzylamino)carbene)chromium(0).

Y. Satoh, L. Hegedus, C. Borel, 1987 .

Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor.

Philip Chamberlain, Y. Satoh, B. Bennett, 2012, Bioorganic & medicinal chemistry letters.

JNK: a new therapeutic target for diabetes.

Y. Satoh, B. Bennett, A. Lewis, 2003, Current opinion in pharmacology.

Inhibitors of the MAPK pathway

Y. Satoh, B. Stein, B. Murray, 2000 .

Discovery of the c-Jun N-Terminal Kinase Inhibitor CC-90001.

Y. Satoh, B. Bennett, D. Mortensen, 2021, Journal of medicinal chemistry.

Derivatives of 2-[[N-(Aminocarbonyl)-N-hydroxyamino]methyl]-1,4- benzodioxan as orally active 5-lipoxygenase inhibitors.

T. Kowalski, L. Toledo, Y. Satoh, 1995, Journal of Medicinal Chemistry.

Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria.

Y. Satoh, T. Matsuo, M. Kuno, 1998, Pancreas.

A stereospecific synthesis of (Z)-δ-halo-γ,δ-unsaturated ketones via haloboration reaction of terminal alkynes

Y. Satoh, S. Hara, A. Suzuki, 1985 .

SYNTHESIS OF 4-SUBSTITUTED PHENYLALANINES BY CROSS-COUPLING REACTIONS : EXTENSION OF THE METHODOLOGY TO ARYL CHLORIDES

Y. Satoh, C. Gude, F. Firooznia, 1998 .

Aryl radical cyclizations: one-Pot syntheses of protoberberine and pavine alkaloids.

Y. Satoh, R. Harada, K. Orito, 2000, Organic letters.

Development of a Water Tolerant Solid Acid Catalyst with a Low Hydraulic Resistance Using the Ice Templating Method

Y. Satoh, S. Mukai, M. Hashimoto, 2011 .

Development of a Strong Acid Ion Exchange Resin with a Monolithic Microhoneycomb Structure Using the Ice Templating Method

Y. Satoh, S. Mukai, 2010 .

HOMOLOGATION OF 1-(BENZYLOXYMETHYL)-1H-TETRAZOLE VIA LITHIATION

Y. Satoh, J. Moliterni, 1998 .

Homologation of 1-(Benzyloxymethyl)-1H-tetrazole via Lithiation.

Y. Satoh, J. Moliterni, 1998 .